Golden Biotechnology Corporation (TPEX: 4132)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
16.55
-0.30 (-1.78%)
Jan 22, 2025, 2:59 PM CST

Golden Biotechnology Company Description

Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore.

Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males.

The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia.

The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Golden Biotechnology Corporation
Country Taiwan
Founded 2002
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 122
CEO Li Yu Wu

Contact Details

Address:
No. 27-6, Zhongzheng E. Road
New Taipei City, 251
Taiwan
Phone 886 2 2808 6006
Website goldenbiotech.com

Stock Details

Ticker Symbol 4132
Exchange Taipei Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004132006
SIC Code 2836

Key Executives

Name Position
Li Yu Wu President and Director
Jun Hua Lian Treasurer